David Weill

TMDX

David Weill serves as director at TransMedics Group, Inc. (TMDX). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

1 trades

$155.0K

Total Sells

5 trades

$2.69M

Net Position

Net Seller

$2.53M

Companies Traded

TMDX

Active Period

Nov 2022 – Mar 2026

6 total trades

Most Recent

Sell TMDX

Mar 6, 2026 · $524.3K

David Weill's Insider Trading at TransMedics Group, Inc. (TMDX)

Buys

1 · $155.0K

Sells

5 · $2.69M

Total Shares Bought

2,500

Total Shares Sold

34,843

TMDX Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Mar 6, 2026	Sell	3,571	$146.82	$524.3K	12,134
May 31, 2024	Sell	1,193	$141.65	$169.0K	10,732
May 14, 2024	Sell	2,500	$129.82	$324.6K	11,193
Aug 30, 2023	Buy	2,500	$62.00	$155.0K	13,693
Feb 28, 2023	Sell	5,934	$76.69	$455.1K	14,970
Nov 14, 2022	Sell	21,645	$56.00	$1.21M	13,500

Related Insiders

Thomas J. Gunderson

director

TMDXSell · Jun 17, 2026

Stephanie Lovell

director

TMDXSell · Mar 6, 2026

Explore More Insider Trading Data

TMDX Insider Trading Activity

View all insider trades at TransMedics Group, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity